Care Network Europe Association Pharmaceutical .2020 .Pharmaceutical Care Network Europe classification for drug related problem V9.1. , : .
Ayalew M. . .Drug related hospital admissions: A systematic review of the recent literatures. ” Bulletin of Emergency and Trauma, 7(2019) : 339-346.
Zanetti A.C. .2020 .Assessment of the incidence and preventability of adverse events in hospitals: An integrative review. , 41 : e20190364.
Haag J.D. . .Prevalence and categorization of drugrelated problems in the emergency department. ” Journal of Emergency Medicine, 63(2022) : 192-199.
Roulet L. . .Adverse drug event nonrecognition in emergency departments: An exploratory study on factors related to patients and drugs. ” Journal of Emergency Medicine, 46(2014) : 857-864.
Roulet L. . .Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital. ” Emergency Medicine Journal, 30(2013) : 63-67.
Zed P.J. .2008 .Incidence, severity and preventability of medication-related visits to the emergency department: A prospective study. ” Canadian Medical Association Journal, 178(12) : 1563-1569.
de Almeida S.M. . .Use of a trigger tool to detect adverse drug reactions in an emergency department. ” BMC Pharmacology and Toxicology, 18(2017) : 71.
Giudice Lo,I. Lo . .Characterization and preventability of adverse drug events as cause of emergency department visits: A prospective 1-year observational study. ” BMC Pharmacology and Toxicology, 20(2019) : 21.
McLachlan C.Y. . .Adverse drug events are a major cause of acute medical admission. Internal Medicine Journal, 44(2014) : 633-638.
Al-Arifi M. . .Emergency department visits and admissions due to drug related problems at Riyadh military hospital. Saudi Arabia.” Saudi Pharmaceutical Journal, 22(2014) : 17-25.
Alshargi O. .2021 .Drug-related problems in emergency department visits and intensive care units at healthcare facilities in Saudi Arabia: A review of the literature. Malaysian Journal of Pharmaceutical Sciences, 19 : 153-169.
Hepler C.D.,Strand L.M. . .Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47(1990) : 533-543.
Nebeker J.R. .2004 .Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting. ” Annals of Internal Medicine, 140(10) : 795-801.
Malhotra S. . .Drug-related visits to the medical emergency department: A prospective study from India. International Journal of Clinical Pharmacology and Therapeutics, 39(2001) : 12-18.
Haynes R.B. .1979 .Compliance in health care. , : .
Hallas J. . .Drug related hospital admissions: The role of definitions and intensity of data collection, and the possibility of prevention. ” Journal of Internal Medicine, 228(1990) : 83-90.
Corporation IBM .2012 .. IBM SPSS Statistics for Windows, version 21.0.” IBM Corporation, : .
Nymoen L.D. . .Drug-related emergency department visits: Prevalence and risk factors. ” Internal and Emergency Medicine, 17(2022) : 1453-1462.
Andres T.M. . .Geriatric pharmacology: An update. ” Anesthesiology Clinics, 37(2019) : 475-492.
de Oliveira L.M. . .Prevalence of drug interactions in hospitalised elderly patients: A systematic review. European Journal of Hospital Pharmacy, 28(2021) : 4-9.
Zanocchi M. .2006 .Adverse drug reactions as cause of visit to the emergency department: Incidence, features and outcomes. , 97(7-8) : 381-388.
Ahern F. . .Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish university hospital: A cross-sectional study. Emergency Medicine Journal, 31(2014) : 24-29.